D-缬氨酰胺盐酸盐, 98%

D-Valinamide hydrochloride

反式-4-（2-丙烯基）环己烷甲酸甲酯

trans-4-(2-Propynyl)cyclohexanecarboxylic Acid Methyl Ester

(4S,5R)-(-)-4-甲基-5-苯基-2-噁唑烷酮, 99%

(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one

Methyl 2-(S)-Acetoxy-3-carboxypropanoate

Methyl 2-(S)-Acetoxy-3-carboxypropanoate

（S）-2-环氧乙烷基乙酸乙酯

ETHYL (S)-3,4-EPOXYBUTANOATE

6-氯D-色氨酸

6-chloro-D-tryptophan

99%

Ethyl (2Z,5S,6E)-5-{[tert-Butyl(dimethyl)silyl]oxy}-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hepta-2,6-dienoate

Ethyl (2Z,5S,6E)-5-{[tert-Butyl(dimethyl)silyl]oxy}-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hepta-2,6-dienoate

(S)-(+)-S-甲基-S-苯亚磺酰亚胺, 97%

(S)-(+)-S-Methyl-S-phenylsulphoximine

≥99.0%

(S)-N-去甲基达泊西汀

(S)-N-Demethyl Dapoxetine

(R)-N-(2-苯甲酰基苯基)-1-苄基吡咯烷-2-甲酰胺, ≥99%

(R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide

(S)-肉碱异丁基酯,氯化物盐

(S)-Carnitine isobutylester chloride salt

1-[（（1S）-1-（羟甲基）丙基]-2-吡咯烷酮

1-[(1S)-1-(Hydroxymethyl)propyl]-2-pyrrolidinone

(R)-4-苄基噁唑烷-2-硫酮, ≥99%,≥99.9% e.e.

(R)-4-Benzyloxazolidine-2-thione

(R)-5,5-二苯基-4-甲基-2-噁唑烷酮, ≥99%,≥99.9% e.e.

(R)-5,5-Diphenyl-4-methyl-2-oxazolidinone

(S)-N-Boc-| A-(碘甲基)苯乙胺

(S)-N-Boc-|A-(iodomethyl)benzeneethanamine

速甾醇

(6E,22E)-(3R)-9,10-secoergosta-5(10),6,8,22-tetraen-3-ol

≥90%

3,4-二甲苯基-6-苯基偶氮-D-核糖胺

3,4-Xylyl-6-phenylazo-D-ribitylamine

2′-O-（叔丁基二甲基甲硅烷基）紫杉醇

2'-O-(tert-Butyldimethylsilyl)taxol

(S)-4-叔丁基-2-噁唑烷酮, 99.9%

(S)-4-tert-Butyl-2-oxazolidinone

6-[(2-乙氧基苯氧基)苯基甲基]-3-吗啉酮

3-Morpholinone, 6-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (6R)-rel-